Was hoping successful outcome of litigation at year-end would help turn this around, but Alfonso hinted that it's (probably) going to continue into '18 in most recent conference call. Secondary products not coming online until 2018 either. I guess we just have to wait for next quarterly. Or we get surprise news that we're doing full roll out into UK on successful trials (probably not for a few months though).
Another Director buying on market, page-12
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
